Robert Hombach, Director at Embecta Corporation, holds 109.59K shares in Embecta Corporation (Ticker: EMBC), holds 13.00K shares in Seaport Therapeutics, Inc. (Ticker: SPTX), holds 49.36K shares in BioMarin Pharmaceutical (Ticker: BMRN). Most recently, Robert Hombach Bought ― shares of Embecta Corporation on Aug 13, 2026 for an estimated value of $223.65K.
Robert Hombach latest transaction was an Informative Buy of $223.65K.
What was Robert Hombach's most profitable transaction?
Robert Hombach’s most profitable transaction was an Informative Buy of SPTX stock on June 24, 2026. The return on the trade was 25.40%.
What is Robert Hombach's role in Embecta Corporation?
Robert Hombach's role in Embecta Corporation is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.